Therasse C (1), Bocquet (1) (2), Fusier I (1), Cordonnier AL (1), Sinègre M (1) (1) General Agency of Equipment and Health Products (AGEPS), AP-HP, Paris, France (2) Paris Dauphine University, Paris, France. Objectives To assess the global economic consequences for French hospitals of the European Commission (EC) decision to strengthen administration conditions of intravenous […]
1. Activités correspondantes du service pour les 37 établissements de l’AP-HP Activités : permanentes décrites dans le contrat du pole dont le service Evaluations Pharmaceutiques et Bon Usage fait partie et qui assure aussi le secrétariat scientifique de la COMEDIMS centrale et la veille prospective des produits de santé de son périmètre. Périmètre : celui du « monopole […]
François Bocquet (1) (2) (3), Pascal Paubel (2), Isabelle Fusier (3), Anne-Laure Cordonnier (3), Claude Le Pen (1), Martine Sinègre (3). (1) Dauphine University, Paris, France, (2) Paris Descartes University, France, (3) General Agency of Equipment and Health Products (AGEPS), Assistance Publique-Hôpitaux de Paris (AP-‐HP), France Objectives Analyze factors influencing Erythropoietins (EPO) biosimilars (copies of […]
François Bocquet (1) (2) (3), Pascal Paubel (3), Isabelle Fusier, Anne-Laure Cordonnier, Claude Le Pen (2), Martine Sinègre. Appl Health Econ Health Policy, 2014; 12 (3) : 315-326. (1) Therapeutic Evaluation Unit, General Agency of Equipment and Health Products (AGEPS), Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France (2) Dauphine University, Paris, France (3) Faculty of […]
Bocquet F (1), (2), (3), Paubel P (2), Fusier I (3), Cordonnier AL (3), Le Pen C (1), Sinègre N (3) (1) Dauphine University, Paris, France, (2) Paris Descartes University, France, (3) General Agency of Equipment and Health Products (AGEPS), Assistance Publique-Hôpitaux de Paris (AP-HP), France Objectives: To determine the ability of biosimilars (copies of […]
MONNIER R, DEGRASSAT-THEAS A, PARENT DE CURZON O, SINEGRE M UF Études Médico-Economiques et Référentiels, Service Evaluations Pharmaceutiques et Bon Usage, AGEPS, AP-HP Objective In France, a forecast growth rate in spending related to the list of expensive hospital drugs, funded in addition to DRG-based payment, is determined annually (2% in 2012) If hospitals exceed […]
Decision-making process to select a fibrinogen concentrates from among different available branded products. F. Dromzée 1,*, F. Bocquet 1, I. Fusier 1, A.-L. Cordonnier 1, N. Poisson 2, M. Sinègre 1 1Therapeutic Evaluation Unit (TEU), General Agency of Equipment and Health Products (AGEPS), AP-HP , 2Drug Purchasing Evaluation Unit, General Agency of Equipment and Health […]
